High-dose fludrocortisone therapy was transiently required in a female neonate with 21-hydroxylase deficiency

For salt-wasting 21-hydroxylase deficiency (21OHD), fludrocortisone (FC) is usually supplemented at 0.05–0.2 mg/d dose. To date, no report has described 21OHD neonates requiring > 0.4 mg/d of FC. Our female 21OHD patient was lethargic and experienced weight loss with hyponatremia (133 mEq/L), hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawasaki, Yusuke, Sato, Takeshi, Nakano, Satsuki, Usui, Takeshi, Narumi, Satoshi, Ishii, Tomohiro, Hasegawa, Tomonobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981041/
https://www.ncbi.nlm.nih.gov/pubmed/35431448
http://dx.doi.org/10.1297/cpe.2021-0066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981041/
https://www.ncbi.nlm.nih.gov/pubmed/35431448
http://dx.doi.org/10.1297/cpe.2021-0066

Ejemplares similares